Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cryo-EM structures of human organic anion transporting polypeptide OATP1B1. | Cell Res | 2023 | 37674011 | PubTator, text mining | PubMed |
| Association of Met420del Variant of Metformin Transporter Gene SLC22A1 with Metformin Treatment Response in Ethiopian Patients with Type 2 Diabetes. | Diabetes Metab Syndr Obes | 2023 | 37641646 | PubTator, text mining | PubMed |
| Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants. | Clin Transl Sci | 2023 | 37639334 | PubTator, text mining | PubMed |
| Preventing mitochondrial reverse electron transport as a strategy for cardioprotection. | Basic Res Cardiol | 2023 | 37639068 | PubTator, text mining | PubMed |
| Machine Learning Techniques Applied to the Study of Drug Transporters. | Molecules | 2023 | 37630188 | PubTator, text mining | PubMed |
| Neuron-Specific Enolase (NSE) as a Biomarker for Autistic Spectrum Disease (ASD). | Life (Basel) | 2023 | 37629593 | PubTator, text mining | PubMed |
| Normative Data for Macular Thickness and Volume for Optical Coherence Tomography in a Diabetic Population without Maculopathies. | J Clin Med | 2023 | 37629274 | PubTator, text mining | PubMed |
| Identification of Novel Intronic SNPs in Transporter Genes Associated with Metformin Side Effects. | Genes (Basel) | 2023 | 37628660 | PubTator, text mining | PubMed |
| SLC22A3 rs2048327 Polymorphism Is Associated with Diabetic Retinopathy in Caucasians with Type 2 Diabetes Mellitus. | Biomedicines | 2023 | 37626799 | PubTator, text mining | PubMed |
| The Impacts of Slc19a3 Deletion and Intestinal SLC19A3 Insertion on Thiamine Distribution and Brain Metabolism in the Mouse. | Metabolites | 2023 | 37623829 | PubTator, text mining | PubMed |
| Towards Evidence-Based Implementation of Pharmacogenomics in Southern Africa: Comorbidities and Polypharmacy Profiles across Diseases. | J Pers Med | 2023 | 37623436 | PubTator, text mining | PubMed |
| metGWAS 1.0: an R workflow for network-driven over-representation analysis between independent metabolomic and meta-genome-wide association studies. | Bioinformatics | 2023 | 37610350 | PubTator, text mining | PubMed |
| Induction of open-form bile canaliculus formation by hepatocytes for evaluation of biliary drug excretion. | Commun Biol | 2023 | 37608051 | PubTator, text mining | PubMed |
| New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System. | CNS Drugs | 2023 | 37603262 | PubTator, text mining | PubMed |
| Interactions of organophosphate flame retardants with human drug transporters. | Ecotoxicol Environ Saf | 2023 | 37597291 | PubTator, text mining | PubMed |
| Discovering metabolic vulnerability using spatially resolved metabolomics for antitumor small molecule-drug conjugates development as a precise cancer therapy strategy. | J Pharm Anal | 2023 | 37577390 | PubTator, text mining | PubMed |
| Differences in the pharmacokinetics and steady-state blood concentrations of orally administered lenvatinib in adult and juvenile rats. | Front Pharmacol | 2023 | 37576809 | PubTator, text mining | PubMed |
| Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies. | Int J Mol Sci | 2023 | 37569903 | PubTator, text mining | PubMed |
| The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism. | Sci Rep | 2023 | 37567965 | PubTator, text mining | PubMed |
| Goldenseal-Mediated Inhibition of Intestinal Uptake Transporters Decreases Metformin Systemic Exposure in Mice. | Drug Metab Dispos | 2023 | 37562957 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=13